Dr. Philip Frost is a clinical professor of medicine at University of California, San Francisco (UCSF) in the Department of Medicine and Cardiovascular Research Institute. He is a clinician, clinical investigator, who for more than 40 years has worked in the field of cardiovascular risk reduction. His book entitled “Little Book for Heart and Blood Vessel Health” is an effort to translate clinical experience accrued in a University lipid clinic and in private practice to the learned lay individual and his/her physician.
As a clinical investigator, he participated in the Coronary Drug Project, the first NIH sponsored clinical trial designed to determine whether lowering cholesterol helped mankind. Later he with others at UCSF participated in the first and subsequent multi-center clinical trials to determine the efficacy and safety and what was initially called mevinolin, later marketed as lovastatin (the first statin), in 1987. In addition to participating as an investigator in multiple other studies assessing lipid lowering agents, he has participated in multiple trials assessing the efficacy and benefits of antihypertensive treatment.